ReviewBiochemistry and biophysics reports2024
CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis.
Mehran Reyhani-Ardabili et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it